PLANNING FOR GENE THERAPY success
With clinical trial successes bringing gene therapy closer to FDA approval and eventual commercialization, it's critical for companies developing gene therapies to understand the marketplace and plan accordingly.
RxC International has put together a white paper containing important information on the current state of gene therapies, companies driving the market forward, and what to consider when beginning the process of commercialization.
CRITICAL QUESTIONS FOR ADDRESSING THE GENE THERAPY Marketplace
- What diseases are closest to having gene therapies approved as treatment options?
- What elements are required for a gene therapy to be successful?
- What are the critical commercial issues companies developing gene therapies need to address?
Gene Therapy Articles and Other Resources
- Gene Therapies: Pathways for Commercial Success: Commercial success for a gene therapy requires as much consideration as regulatory approval. In this article, RxC International provides key insights into the gene therapy market in conversation with ICER’s white paper for the commercial entrance of gene therapies.
GENE THERAPY: Understanding the Science, Assessing the Evidence, and Paying for Value: The Institute for Clinical and Economic Review (ICER) convened a policy summit in late 2016 to evaluate potential value and challenges of gene therapy treatments. This is a report of their findings and suggestions.